US Patent Issued to HANGZHOU SHENGTING MEDICAL TEHCNOLOGY on Aug. 4 for "Multi-cancer detection and traceability systems based on DNA high-throughput methylation sequencing" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,535, issued on Aug. 4, was assigned to HANGZHOU SHENGTING MEDICAL TEHCNOLOGY Co. LTD (Hangzhou, China).

"Multi-cancer detection and traceability systems based on DNA high-throughput methylation sequencing" was invented by Hongcang Gu (Hangzhou, China), Yunfei Wang (Hangzhou, China), Jian Huang (Hangzhou, China) and Qian Wang (Hangzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are multi-cancer detection and traceability systems based on DNA high-throughput methylation sequencing. The multi-cancer detection system includes a first sample sequencing module used for sequencing sample DNA, a methylation feature set acquisition module ...